MetaVia Inc. (MTVA): Total Assets
$11.12M
As of 2025-12-31
$13.27M
As of 2026-06-30
-30.8%
3-year compound annual growth
+0.3%
5-year compound annual growth
+9.5%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.12M | -31.6% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $16.26M | -28.6% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $22.78M | -32.1% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $33.53M | +99.6% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $16.80M | +53.2% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $10.97M | -24.2% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $14.47M | +278.7% | 2021-04-15, Balance as of period end |
| 2018-12-31 | $3.82M | -79.9% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $19.02M | -23.2% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $24.75M | +451.3% | 2018-03-20, Balance as of period end |
| 2015-12-31 | $4.49M | n/a | 2017-03-21, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| MetaVia Inc. (MTVA) | 2025-12-31 | $11.12M | -31.6% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $11.09M | +279.5% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $11.06M | +265.8% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $11.04M | -56.8% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $11.45M | n/m |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.58M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $11.58M | +74.9% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $10.62M | -57.5% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $10.48M | +318.0% |
Compare MTVA, MIRA, DCOY, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗